Enveric Biosciences, Inc.
ENVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,874 | -$2,519 | -$2,185 | -$3,155 |
| Dep. & Amort. | $40 | $40 | $81 | $82 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $206 | $194 | $472 |
| Change in WC | -$300 | $383 | -$479 | $877 |
| Other Non-Cash | $58 | $0 | -$3 | $412 |
| Operating Cash Flow | -$2,075 | -$1,890 | -$2,392 | -$1,312 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,992 | $449 | $4,449 | -$2,405 |
| Stock Repurch. | $0 | $0 | $0 | $1,084 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1,784 |
| Financing Cash Flow | $2,992 | $449 | $4,449 | $463 |
| Forex Effect | -$10 | -$4 | -$4 | -$23 |
| Net Chg. in Cash | $908 | -$1,445 | $2,053 | -$871 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,850 | $4,294 | $2,241 | $3,112 |
| End Cash | $3,758 | $2,850 | $4,294 | $2,241 |
| Free Cash Flow | -$2,075 | -$1,890 | -$2,392 | -$1,312 |